5ZR3
Crystal structure of Hsp90-alpha N-terminal domain in complex with 4-(3-isopropyl-4-(4-(1-methyl-1H-pyrazol-4-yl)-1H-imidazol-1-yl)-1H-pyrazolo[3,4-b]pyridin-1-yl)-3-methylbenzamide
Summary for 5ZR3
Entry DOI | 10.2210/pdb5zr3/pdb |
Descriptor | Heat shock protein HSP 90-alpha, 3-methyl-4-{4-[4-(1-methyl-1H-pyrazol-4-yl)-1H-imidazol-1-yl]-3-(propan-2-yl)-1H-pyrazolo[3,4-b]pyridin-1-yl}benzamide (3 entities in total) |
Functional Keywords | inhibitor, complex, chaperone |
Biological source | Homo sapiens (Human) |
Total number of polymer chains | 4 |
Total formula weight | 108721.69 |
Authors | Uno, T.,Chong, K.T.,Suzuki, T. (deposition date: 2018-04-23, release date: 2019-01-02, Last modification date: 2023-11-22) |
Primary citation | Uno, T.,Kawai, Y.,Yamashita, S.,Oshiumi, H.,Yoshimura, C.,Mizutani, T.,Suzuki, T.,Chong, K.T.,Shigeno, K.,Ohkubo, M.,Kodama, Y.,Muraoka, H.,Funabashi, K.,Takahashi, K.,Ohkubo, S.,Kitade, M. Discovery of 3-Ethyl-4-(3-isopropyl-4-(4-(1-methyl-1 H-pyrazol-4-yl)-1 H-imidazol-1-yl)-1 H-pyrazolo[3,4- b]pyridin-1-yl)benzamide (TAS-116) as a Potent, Selective, and Orally Available HSP90 Inhibitor. J. Med. Chem., 62:531-551, 2019 Cited by PubMed: 30525599DOI: 10.1021/acs.jmedchem.8b01085 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.5 Å) |
Structure validation
Download full validation report